// company-profile
Transcode Therapeutics, Inc.
RNAZExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings17Insiders5
// api This Transcode Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
No insider activity recorded for RNAZ in the last 90 days.
Institutional Ownership
Top 13F-HR holders of Transcode Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$240,002
QoQ change
—
Reporting period
2026-03-31
#1
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$94,382
11K shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$56,352
7K shares
#3
UBS Group AG
CIK 1610520
$53,718
6K shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 14, 2024 | Marquet Magda | RNAZ | Award | 70,000 | $0.00 | $0K |
| Jun 14, 2024 | Calais Philippe | RNAZ | Award | 70,000 | $0.00 | $0K |
| Jun 14, 2024 | Fitzgerald Thomas A | RNAZ | Award | 650,000 | $0.00 | $0K |
| Jun 14, 2024 | Manting Erik | RNAZ | Award | 70,000 | $0.00 | $0K |
| Sep 28, 2023 | Dudley Robert Michael | RNAZ | Purchase | 98,000 | $0.51 | $50K |
12 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.